scholarly article | Q13442814 |
P2093 | author name string | Michael S Gordon | |
Kevin E O'Grady | |||
Bikash Sharma | |||
Frank J Vocci | |||
Marc Fishman | |||
Faye Taxman | |||
Thomas R Blue | |||
P2860 | cites work | Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence | Q24239965 |
Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies | Q26749305 | ||
EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders | Q30277067 | ||
Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system | Q30423352 | ||
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program | Q33844064 | ||
Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience | Q33845768 | ||
A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry | Q34030894 | ||
Allocation concealment in randomised trials: defending against deciphering | Q34116070 | ||
Interim methadone treatment compared to standard methadone treatment: 4-month findings | Q35032405 | ||
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users | Q35167576 | ||
Comparison of buprenorphine treatment for opioid dependence in 3 settings | Q35748679 | ||
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions | Q35808493 | ||
Bridging waitlist delays with interim buprenorphine treatment: initial feasibility | Q36021346 | ||
Substance abuse and dependence in prisoners: a systematic review. | Q36381396 | ||
A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans | Q36579283 | ||
Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes | Q36698474 | ||
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone | Q37393366 | ||
Interim Buprenorphine vs. Waiting List for Opioid Dependence | Q37729994 | ||
Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene | Q41038100 | ||
Buprenorphine and medication management in a community corrections population: a pilot study | Q42596160 | ||
Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies | Q43188947 | ||
Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year | Q43687286 | ||
A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway | Q44008328 | ||
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale | Q46572937 | ||
A randomized controlled trial of interim methadone maintenance | Q46876478 | ||
The Fifth Edition of the Addiction Severity Index | Q51700999 | ||
Outcomes of buprenorphine maintenance in office-based practice. | Q51902147 | ||
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. | Q52271086 | ||
The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. | Q52274533 | ||
A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. | Q53594572 | ||
A randomized trial of an interim methadone maintenance clinic | Q68263289 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 21-27 | |
P577 | publication date | 2019-02-20 | |
P1433 | published in | Contemporary Clinical Trials | Q5164971 |
P1476 | title | A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment | |
P478 | volume | 79 |
Search more.